Literature DB >> 21892413

An Etiological Model for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Leonard A Jason1, Matthew Sorenson, Nicole Porter, Natalie Belkairous.   

Abstract

Kindling might represent a heuristic model for understanding the etiology of Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS). Kindling occurs when an organism is exposed repeatedly to an initially sub-threshold stimulus resulting in hypersensitivity and spontaneous seizure-like activity. Among patients with ME/CFS, chronically repeated low-intensity stimulation due to an infectious illness might cause kindling of the limbic-hypothalamic-pituitary axis. Kindling might also occur by high-intensity stimulation (e.g., brain trauma) of the limbic-hypothalamic-pituitary axis. Once this system is charged or kindled, it can sustain a high level of arousal with little or no external stimulus and eventually this could lead to hypocortisolism. Seizure activity may spread to adjacent structures of the limbic-hypothalamic-pituitary axis in the brain, which might be responsible for the varied symptoms that occur among patients with ME/CFS. In addition, kindling may also be responsible for high levels of oxidative stress, which has been found in patients with ME/CFS.

Entities:  

Year:  2011        PMID: 21892413      PMCID: PMC3166239          DOI: 10.4236/nm.2011.21003

Source DB:  PubMed          Journal:  Neurosci Med        ISSN: 2158-2912


  85 in total

1.  The role of TNF-alpha in amygdala kindled rats.

Authors:  A A Shandra; L S Godlevsky; R S Vastyanov; A A Oleinik; V L Konovalenko; E N Rapoport; N N Korobka
Journal:  Neurosci Res       Date:  2002-02       Impact factor: 3.304

2.  Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?

Authors:  Boudewijn Van Houdenhove; Filip Van Den Eede; Patrick Luyten
Journal:  Med Hypotheses       Date:  2009-02-23       Impact factor: 1.538

3.  Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.

Authors:  A J Cleare; V O'Keane; J P Miell
Journal:  Psychoneuroendocrinology       Date:  2004-07       Impact factor: 4.905

4.  Epstein-Barr virus encephalitis and encephalomyelitis: MR findings.

Authors:  W J Shian; C S Chi
Journal:  Pediatr Radiol       Date:  1996-09

5.  Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome.

Authors:  M Robinson; S R Gray; M S Watson; G Kennedy; A Hill; J J F Belch; M A Nimmo
Journal:  Scand J Med Sci Sports       Date:  2009-04-13       Impact factor: 4.221

6.  Identification of marker genes for differential diagnosis of chronic fatigue syndrome.

Authors:  Takuya Saiki; Tomoko Kawai; Kyoko Morita; Masayuki Ohta; Toshiro Saito; Kazuhito Rokutan; Nobutaro Ban
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

7.  Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Jonathan R Kerr; Robert Petty; Beverley Burke; John Gough; David Fear; Lindsey I Sinclair; Derek L Mattey; Selwyn C M Richards; Jane Montgomery; Don A Baldwin; Paul Kellam; Tim J Harrison; George E Griffin; Janice Main; Derek Enlander; David J Nutt; Stephen T Holgate
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

8.  Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.

Authors:  Konrad A Bode; Kate Schroder; David A Hume; Timothy Ravasi; Klaus Heeg; Matthew J Sweet; Alexander H Dalpke
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

Review 9.  Stressor controllability and learned helplessness research in the United States: sensitization and fatigue processes.

Authors:  Thomas R Minor; Aimee M Hunter
Journal:  Integr Physiol Behav Sci       Date:  2002 Jan-Mar

10.  Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association.

Authors:  Virginia R Falkenberg; Brian M Gurbaxani; Elizabeth R Unger; Mangalathu S Rajeevan
Journal:  Neuromolecular Med       Date:  2010-10-13       Impact factor: 3.843

View more
  7 in total

1.  Depression, evening salivary cortisol and inflammation in chronic fatigue syndrome: A psychoneuroendocrinological structural regression model.

Authors:  Sara F Milrad; Daniel L Hall; Devika R Jutagir; Emily G Lattie; Sara J Czaja; Dolores M Perdomo; Mary Ann Fletcher; Nancy Klimas; Michael H Antoni
Journal:  Int J Psychophysiol       Date:  2017-09-14       Impact factor: 2.997

2.  Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Leonard A Jason; Samuel Yoo; Shaun Bhatia
Journal:  Chronic Illn       Date:  2021-09-20

3.  Energy Conservation/Envelope Theory Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Leonard A Jason; Molly Brown; Abigail Brown; Meredyth Evans; Samantha Flores; Elisa Grant-Holler; Madison Sunnquist
Journal:  Fatigue       Date:  2012-08-08

4.  Cognitive impairments associated with CFS and POTS.

Authors:  Lindzi Shanks; Leonard A Jason; Meredyth Evans; Abigail Brown
Journal:  Front Physiol       Date:  2013-05-16       Impact factor: 4.566

Review 5.  Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Authors:  Leonard A Jason; Marcie L Zinn; Mark A Zinn
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

6.  A case of chronic fatigue syndrome improved by traditional Korean medicine.

Authors:  Chang-Gue Son
Journal:  Integr Med Res       Date:  2013-01-31

7.  The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Julian A G Glassford
Journal:  Front Physiol       Date:  2017-02-17       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.